← Evidence map

ArticleOncoTargets and therapy2016

Clinical efficacy and safety of T-DM1 for patients with HER2-positive breast cancer.

Bo Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

8 papers cite it

2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 27013890